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Abstract
Background: Diabetic subjects, especially women, show high prevalence of asymptomatic bacteriuria (ASB). The aim 
of the present study was to evaluate the prevalence of ASB in subjects with type 2 diabetes mellitus (T2D) with and 
without microalbuminuria (MA).
Findings: A hundred diabetic subjects with MA (53 males/47 females, mean age ± standard deviation: 65.5 ± 11.1 
years) and 100 diabetic subjects without MA (52 males/48 females, mean age ± standard deviation: 65.4 ± 11.3 years), 
consecutively attending the outpatient diabetes clinic of our hospital were recruited in the study. Subjects with overt 
diabetic nephropathy or nephropathy from other causes were excluded. In addition, subjects with symptoms of 
urinary track infection or use of antimicrobial drugs in the last 14 days were excluded by the study.
Diabetic subjects with MA showed increased prevalence of ASB compared to diabetic subjects without MA (21%
versus 8%, P < 0.001, respectively). Escherichia coli was the most prevalent pathogen isolated in diabetic subjects with
and without MA (12% versus 3.0%, P = 0.01, respectively) followed by Proteus mirabilis (6% versus 5%, P = 0.75,
respectively) and Klebsiella spp (5% versus 1%, P = 0.09, respectively). Univariate logistic analysis showed that ASB
was associated with the presence of coronary artery disease [odds ratio (OR): 0.29, 95% Confidence Intervals (95% CI):
0.09-0.95, P = 0.04] and gender (OR: 0.09, 95% CI: 0.02-0.35, P < 0.001) in the diabetic study group with MA.
Conclusions: ASB is more prevalent among T2D subjects with MA. Screening for ASB is warranted in diabetic patients 
especially if pyuria is detected in urine analysis since ASB has been found to be a risk factor for developing 
symptomatic urinary tract infection.
Background
Urinary tract infections (UTIs) as well as their complica-
tions, such as emphysematous cystitis, pyelonephritis and
renal papillary necrosis occur more commonly in sub-
jects with type 2 diabetes mellitus (T2D) [1-3]. In addi-
tion, many studies have showed that diabetic subjects,
especially women, show high prevalence of asymptomatic
bacteriuria (ASB) [4-7]. In diabetic women, various risk
factors for ASB have been suggested including age, pres-
ence of macroalbuminuria, low body mass index (BMI)
and UTIs during the previous year [7]. In a prior study,
ASB was a risk factor for subsequent decline in renal
function among women with type 1 diabetes mellitus [8].
Microalbuminuria (MA) is a common complication of
T2D affecting almost 30-50% of the patients with T2D
[9,10]. Presence of MA has been related with high blood
pressure, dyslipidemia, inflammation, endothelial dys-
function, left ventricular hypertrophy and hypercoagula-
tion [11]. However, little evidence exists regarding the
relationship between ASB and MA in T2D subjects.
Therefore, the aim of the present study was to evaluate
the prevalence of ASB in T2D subjects with and without
MA and to determine possible risk factors affecting the
presence of ASB in diabetic subjects. * Correspondence: pathan@ath.forthnet.gr
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Methods
A hundred diabetic subjects with MA (53 males/47
females, mean age ± standard deviation: 65.5 ± 11.1
years) and 100 diabetic subjects without MA (52 males/
48 females, mean age ± standard deviation: 65.4 ± 11.3
years), consecutively attending the outpatient diabetes
clinic of our hospital were recruited in the study. The
physical examination and the interview of the subjects
were carried based on a study protocol by the investiga-
tors. Subjects with overt diabetic nephropathy (proteinu-
ria) or nephropathy from other causes were excluded. In
addition, subjects with symptoms of UTI (including dys-
uria, frequency, fever, urgency and abdominal discom-
fort) or use of antimicrobial drugs in the last 14 days were
excluded by the study.
All participants underwent complete physical examina-
tion in the morning of the study. They were questioned
about previous and current diseases, use of medications
and their smoking habits; ex-smokers who had given up
smoking for a period of at least three years were consid-
ered as non-smokers. Retinopathy was reported from the
medical records. Body weight with subjects in light cloth-
ing without shoes and height was measured and body
mass index (BMI) was calculated. Waist circumference
w a s  m e a s u r e d  w i t h  a  s o f t  t a p e  o n  s t a n d i n g ,  m i d w a y
between the lowest rib and the iliac crest.
Blood pressure was measured in the right arm three
consecutive times, one minute apart, in the sitting posi-
tion after 10 min resting period, using an appropriate cuff
size. The mean value of the last two measurements was
used in the statistical analysis. Arterial hypertension was
defined according to the current guidelines if systolic
blood pressure was ≥140 mmHg and/or diastolic blood
pressure ≥ 90 mmHg or if patients were on antihyperten-
sive treatment [12].
Blood was collected after an overnight fast of at least 12
hours. Serum glucose, lipids [total cholesterol, high den-
sity lipoprotein (HDL) cholesterol, triglycerides] and cre-
atinine were measured enzymatically on a Technicon RA-
XT analyzer (Technicon Ltd, Dublin, Ireland). Low den-
sity lipoprotein (LDL) cholesterol was calculated using
the formula of Friedwald et al [13]. Glomerular filtration
rate was calculated according to the equation of Cock-
croft and Gault [14]. HbA1c  was measured by HPLC
(Roche diagnostics, Mannheim, Germany) with a non-
diabetic reference range of 4.1-6.0%. Microalbuminuria
was diagnosed when albumin excretion rate (AER), mea-
sured by radioimmunoassay (RIA) (Pharmacia, Pharma-
cia and Upjon Diagnostics AB, Upsala, Sweden), was 30-
300 mg/24-hours in at least two out of three 24-hours
urine collections over a three month period.
Midstream clean voiding urinary specimens were col-
lected for urinalysis, microscopy, culture and sensitivity.
The specimens were refrigerated immediately and cul-
tured within 2 hours. All urine samples were cultured on
Blood and MacConkey agar plates. The plates were incu-
bated at 37°C aerobically for 48 hours. Bacteriuria was
defined as the presence of at least 105 colony forming
units/ml of 1 or 2 bacterial species in a culture of clean-
voided midstream urine confirmed by a second culture.
Presence of at least three different microorganisms in a
urine specimen was considered as contamination [15].
The study protocol was approved by the Scientific and
Ethical Committee of the General Hospital of Nikaia. Full
informed written consent was obtained from all patients.
Statistical analysis
Analyses were performed using the SPSS 15.0 (SPSS, IL,
USA) statistical package. All variables were tested for
normal distribution of the data. Data are presented as
means ± standard deviation or percentages. Differences
between the studied groups examined using the student's
unpaired t-test or the Mann-Whitney U-test for paramet-
ric and non-parametric data, respectively, while a chi-
square test was used for categorical data. Bivariate corre-
lations were performed using the Pearson or the Spear-
man correlation coefficient, as appropriate. Univariate
b i n a ry  l o g i s t i c  a n a l y s i s  w a s  p e r f o r m e d  t o  l o o k  f o r  t h e
relationship between ASB and the variables of interest in




More diabetic subjects with MA had coronary artery dis-
ease (CAD) (39% versus 23%, P < 0.01, respectively) and
hypertension (87% versus 72%, P < 0.001, respectively)
compared to diabetic subjects without MA. In addition,
diabetic subjects with MA had higher levels of plasma
urea (P < 0.001) and creatinine (P = 0.03) than diabetic
subjects without MA. Patients with and without MA did
not differ significantly in terms of age, BMI, duration of
diabetes, glycemic control, systolic and diastolic arterial
pressure, lipid profile, diabetic complications and treat-
ment for diabetes (Table 1).
Prevalence of ASB and isolated pathogens
Diabetic subjects with MA showed increased prevalence
of ASB compared to diabetic subjects without MA (21%
versus 8%, P < 0.001, respectively). Escherichia coli was
the most prevalent pathogen isolated in diabetic subjects
with and without MA (12% versus 3.0%, P = 0.01, respec-
tively) followed by Proteus mirabilis (6% versus 5%, P =
0.75, respectively) and Klebsiella spp (5% versus 1%, P =
0.09, respectively).
Univariate logistic analysis showed that ASB was asso-
ciated with the presence of CAD [odds ratio (OR): 0.29,
95% Confidence Intervals (95% CI): 0.09-0.95, P = 0.04]Papazafiropoulou et al. BMC Research Notes 2010, 3:169
http://www.biomedcentral.com/1756-0500/3/169
Page 3 of 5
and gender (OR: 0.09, 95% CI: 0.02-0.35, P < 0.001) in the
diabetic study group with MA. No any significant rela-
tionships were found between ASB and the rest of the
v a r i a b l e s .  T h e  s a m e  p a t t e r n  w a s  o b s e r v e d  i n  d i a b e t i c
study group without MA (Table 2).
Discussion
I t  i s  w e l l  d o c u m e n t e d  t h a t  T 2 D  p a t i e n t s  s h o w e d
increased prevalence of ASB [4-7]. The novel finding of
the present study was that diabetic subjects with MA
showed high prevalence of ASB compared to diabetics
without MA. This result is in accordance with findings of
two recent studies [16,17]. The first study showed that
macroalbuminuria and serum creatinine were indepen-
dent and significant risk factors for ASB in T2D women
[16]. The second study, similarly, showed that the main
risk factors for ASB in diabetic patients were female gen-
der and urinary albumin excretion [17]. The same obser-
vation was made in type 1 diabetic (T1D) subjects. A
study in children and adolescents with T1D showed that
microalbuminuria and microvascular complications were
significant risk factors for ASB [18]. In T1D women ASB
was related with the presence of macroalbuminuria [7].
Therefore, a simply explanation might be that albuminu-
ria, as an expression of structural damage in the kidney,
might increase the vulnerability to bacterial attacks, thus
resulting in an increased risk of developing ASB [7].
In the present study the most common isolated patho-
gen was Escherichia coli i n  d i a b e t i c  s u b j e c t s  w i t h  a n d
without MA. Previous studies have showed that Escheri-
chia coli is the most common pathogen in diabetic sub-
jects either with ASB or with clinical manifestations of
UTIs [19,20]. However, one study had different results
showing that Klebsiella spp was the most common patho-
gen in T2D subjects with ASB [21]. In the present study
Klebsiella spp was the third in row isolated pathogen in
both groups.
Confirming previous results [5-7] we showed that in
the diabetic group with MA presence of ASB was related
with female gender. Further analysis of our data showed a
relationship between ASB and CAD in the diabetic study
group with MA. A simply explanation is that the group
with MA had more CAD subjects than the group without
MA and this might in part explain the above finding.
However, a study in outpatient women showed higher
prevalence of CAD among women with ASB in compari-
son with women without ASB [22].
Despite evidence from previous studies [7,23] we failed
to show any relationship between ASB and age as well as
BMI. However, other studies were in accordance with our
results showing no significant association between ASB
and age as well as BMI [16,20,24]. Also, no significant
relationships were found between ASB and duration of
diabetes, glycemic control and microvascular complica-
tions. However, the evidences by the literature are con-
flicting [6,7,25-27]. A study in T1D women showed that
risk factors for ASB were a longer duration of diabetes
and the presence of peripheral neuropathy [7]. In addi-
tion, presence of longstanding complications, such as
Table 1: Demographic and clinical characteristics of diabetic 
subjects with and without microalbuminuria (MA)
MA (+) MA (-) P
Males/females 53/47 52/48 0.88
Age (years) 65.5 ± 11.1 65.4 ± 11.3 0.94
Waist (cm) 105.5 ± 11.4 104.1 ± 12.5 0.82
Current smokers 45 44 0.88
Duration of diabetes (years) 14.7 ± 7.8 13.6 ± 8.2 0.39
HbA1c (%) 7.6 ± 1.4 8.1 ± 1.4 0.46
Body mass index (Kg/m2) 32.7 ± 8.3 31.4 ± 6.2 0.18
Systolic blood pressure (mm 
Hg)
140.9 ± 18.1 141.2 ± 18.2 0.92
Diastolic blood pressure 
(mm Hg)
75.7 ± 10.2 76.9 ± 12.8 0.47
Glucose (mg/dl) 156.8 ± 44.6 155.9 ± 53.8 0.89
Total cholesterol (mg/dl) 178.3 ± 54.9 176.6 ± 38.4 0.81
HDL cholesterol (mg/dl) 48.6 ± 14.7 49.9 ± 15.2 0.54
LDL cholesterol (mg/dl) 98.8 ± 35.5 101.3 ± 32.7 0.54
Triglycerides (mg/dl) 145.4 ± 38.0 133.9 ± 32.9 0.34
Urea (mg/dl) 47.2 ± 14.1 37.0 ± 12.7 < 0.001
Creatinine (mg/dl) 1.1 ± 0.6 0.9 ± 0.3 0.03
CAD (yes) 39 23 0.01
Retinopathy (yes) 44 39 0.47
Hypertension (yes) 87 72 < 0.001
Hyperlipidemia (yes) 74 81 0.24
Treatment for diabetes - - -
Antidiabetic tablets 71 73 0.75
Insulin 63 54 0.75
P values for the comparison between subjects with and without MA 
by independent samples t-test for continuous variables or by 
Pearson χ2 for nominal variables.
HDL: high density lipoprotein; LDL: low density lipoprotein; CAD: 
coronary artery disease; PAD: peripheral artery disease.Papazafiropoulou et al. BMC Research Notes 2010, 3:169
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peripheral neuropathy and peripheral vascular disease
has been showed to be associated with ASB [6,25]. How-
ever, these findings could not be confirmed by other stud-
ies [26,27]. Finally, in accordance with other studies, our
data showed no significant associations between glycemic
control, in terms of HbA1c, and ASB [7,8].
Our study has some limitations. First of all, as it is men-
tioned above, the two study groups were not comparable
regarding the prevalence of CAD. In addition, the size of
the study sample was rather small to conclude possible
associations between ASB and the testing variables.
Finally, as data were collected from a referral tertiary cen-
ter, they cannot be extrapolated to the total diabetic pop-
ulation.
In conclusion, ASB is more prevalent among T2D sub-
jects with MA. Screening for ASB is warranted in dia-
betic patients especially if pyuria is detected in urine
analysis since ASB has been found to be a risk factor for
developing symptomatic urinary tract infection [28].
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Table 2: Univariate logistic analysis: the association between various parameters with ASB in diabetic subjects with and without 
microalbuminuria (MA)
MA (+) MA (-)
Odds ratio 95% Confidence Intervals P-value Odds ratio 95% Confidence Intervals P-value
Gender (males vs. females) 0.09 0.02-0.35 < 0.001 0.98 0.88-1.17 0.61
Age 0.99 0.95-1.04 0.98 1.01 0.94-1.08 0.67
Waist 0.97 0.85-1.02 0.81 1.02 0.98-1.08 0.81
Current smokers 0.89 0.34-2.36 0.82 1.30 0.31-5.51 0.72
Duration of diabetes 0.99 0.95-1.04 0.91 1.05 0.97-1.14 0.19
HbA1c 0.78 0.52-1.16 0.23 0.77 0.41-1.42 0.41
Body mass index 1.03 0.97-1.08 0.30 1.05 0.96-1.16 0.24
Systolic blood pressure 0.99 0.96-1.02 0.53 1.01 0.97-1.05 0.41
Diastolic blood pressure 0.99 0.94-1.04 0.81 1.05 0.99-1.11 0.09
Glucose 0.99 0.98-1.00 0.42 1.01 0.94-1.02 0.21
Total cholesterol 0.99 0.98-1.00 0.29 1.01 0.99-1.02 0.31
HDL cholesterol 0.97 0.93-1.02 0.30 1.05 0.97-1.09 0.09
LDL cholesterol 0.99 0.98-1.01 0.49 1.02 0.97-1.04 0.85
Triglycerides 0.99 0.9901.00 0.51 1.04 0.99-1.05 0.25
Urea 1.01 0.98-1.02 0.58 1.02 0.97-1.07 0.39
Creatinine 0.79 0.30-2.11 0.64 1.82 0.18-17.98 0.61
CAD 0.29 0.09-0.95 0.04 0.45 0.05-3.90 0.47
Retinopathy 0.94 0.35-2.49 0.91 1.62 0.38-6.93 0.51
Hypertension 1.53 0.31-7.53 0.59 0.62 0.14-2.71 0.53
Hyperlipidemia 1.64 0.49-5.42 0.41 0.68 0.12-3.60 0.65Papazafiropoulou et al. BMC Research Notes 2010, 3:169
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